Form 4: Insmed Executive Sells Shares After Performance Stock Units Vest

Insmed's Chief People Strategy Officer, S. Nicole Schaeffer, sold 23,500 shares to cover tax obligations after the vesting of Performance Stock Units.

Summary

• S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., reported changes in beneficial ownership of the company's stock.
• On February 5, 2025, 47,295 shares of common stock were acquired upon the vesting of Performance Stock Units (PSUs) granted on January 6, 2022.
• These PSUs vested due to the achievement of applicable performance and service conditions.
• On February 6, 2025, 23,500 shares were sold at a weighted average price of $80.9 per share, ranging from $80.57 to $81.43, to satisfy tax withholding obligations and cover broker fees.
• Following these transactions, Schaeffer directly owns 120,878 shares of Insmed common stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Sales to cover tax obligations are common after vesting events.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market, but it's unlikely to be significant given the relatively small volume.

Key Dates